One of Graham's other observation is that the market tend to focus too much on earnings and nearly not enough on what has been invested into the company - its assets and its position.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025